New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.

The POU transcription factor Oct-4 is expressed specifically in the germ line, pluripotent cells of the pregastrulation embryo and stem cell lines derived from the early embryo. Osteopontin (OPN) is a protein secreted by cells of the preimplantation embryo and contains a GRGDS motif that can bind to specific integrin subtypes and modulate cell adhesion/migration. We show that Oct-4 and OPN are coexpressed in the preimplantation mouse embryo and during differentiation of embryonal cell lines. Immunoprecipitation of the first intron of OPN (i-opn) from covalently fixed chromatin of embryonal stem cells by Oct-4-specific antibodies indicates that Oct-4 binds to this fragment in vivo. The i-opn fragment functions as an enhancer in cell lines that resemble cells of the preimplantation embryo. Furthermore, it contains a novel palindromic Oct factor recognition element (PORE) that is composed of an inverted pair of homeodomain-binding sites separated by exactly 5 bp (ATTTG +5 CAAAT). POU proteins can homo- and heterodimerize on the PORE in a configuration that has not been described previously. Strong transcriptional activation of the OPN element requires an intact PORE. In contrast, the canonical octamer overlapping with the downstream half of the PORE is not essential. Sox-2 is a transcription factor that contains an HMG box and is coexpressed with Oct-4 in the early mouse embryo. Sox-2 represses Oct-4 mediated activation of i-opn by way of a canonical Sox element that is located close to the PORE. Repression depends on a carboxy-terminal region of Sox-2 that is outside of the HMG box. Expression, DNA binding, and transactivation data are consistent with the hypothesis that OPN expression is regulated by Oct-4 and Sox-2 in preimplantation development.

[1]  H. Schöler,et al.  Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. , 1996, Development.

[2]  H. Schöler,et al.  Octamania: the POU factors in murine development. , 1991, Trends in genetics : TIG.

[3]  N. Heintz,et al.  Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. , 1991, Science.

[4]  G. Kidder,et al.  Regulation of Na+,K+-ATPase α Subunit Gene Expression during Mouse Preimplantation Development , 1994 .

[5]  Gert Vriend,et al.  Prediction and analysis of structure, stability and unfolding of thermolysin-like proteases , 1993, J. Comput. Aided Mol. Des..

[6]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[7]  N. Hillman,et al.  Ultrastructural studies of the mouse blastocyst substages. , 1974, Journal of embryology and experimental morphology.

[8]  E. Adamson,et al.  Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm , 1981, Nature.

[9]  A. Gronenborn,et al.  Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex , 1995, Cell.

[10]  P. Goodfellow,et al.  A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. , 1996, Development.

[11]  Renato Paro,et al.  Mapping polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin , 1993, Cell.

[12]  M. Karin,et al.  M-phase-specific phosphorylation of the POU transcription factor GHF-1 by a cell cycle-regulated protein kinase inhibits DNA binding , 1995, Molecular and cellular biology.

[13]  H. Schöler,et al.  Oct‐4: a germline‐specific transcription factor mapping to the mouse t‐complex. , 1990, The EMBO journal.

[14]  T. Wirth,et al.  High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. , 1995, The EMBO journal.

[15]  M. Wegner,et al.  Variable effects of phosphorylation of pit-1 dictated by the DNA response elements , 1991 .

[16]  C. Basilico,et al.  Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer , 1994, Molecular and cellular biology.

[17]  M. Wegner,et al.  Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y , 1995, Molecular and cellular biology.

[18]  D. Ambrosetti,et al.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites , 1997, Molecular and cellular biology.

[19]  W. Herr,et al.  The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. , 1995, Genes & development.

[20]  R. Pedersen,et al.  Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. , 1995, Genes & development.

[21]  Z. Werb,et al.  Cooperative interactions between extracellular matrix, integrins and parathyroid hormone-related peptide regulate parietal endoderm differentiation in mouse embryos. , 1995, Development.

[22]  D. Denhardt,et al.  Osteopontin: a protein with diverse functions , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  S. Strickland,et al.  Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP , 1980, Cell.

[24]  Alexander Varshavsky,et al.  Mapping proteinDNA interactions in vivo with formaldehyde: Evidence that histone H4 is retained on a highly transcribed gene , 1988, Cell.

[25]  Wiebe Kruijer,et al.  Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells , 1991, Mechanisms of Development.

[26]  C. Basilico,et al.  Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells , 1990, Molecular and cellular biology.

[27]  H. Schöler,et al.  Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. , 1994, Developmental biology.

[28]  C. Verrijzer,et al.  POU proteins bend DNA via the POU‐specific domain. , 1991, The EMBO journal.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[30]  H. Schöler,et al.  Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. , 1989, The EMBO journal.

[31]  Peter W. J. Rigby,et al.  A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo , 1990, Nature.

[32]  N. Corbi,et al.  Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. , 1995, Genes & development.

[33]  H. Schöler,et al.  Regulation of the Oct-4 gene by nuclear receptors. , 1994, Nucleic acids research.

[34]  V. Papaioannou,et al.  Requirement of FGF-4 for postimplantation mouse development , 1995, Science.

[35]  Juli D. Klemm,et al.  Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules , 1994, Cell.

[36]  S. Strickland,et al.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid , 1978, Cell.

[37]  H. Hamada,et al.  A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages , 1993, Neuron.

[38]  Gardner Rl.  Origin and differentiation of extraembryonic tissues in the mouse. , 1983 .

[39]  M. Rosenfeld,et al.  POU domain family values: flexibility, partnerships, and developmental codes. , 1997, Genes & development.

[40]  C. Verrijzer,et al.  POU domain transcription factors. , 1993, Biochimica et biophysica acta.

[41]  R. Kroczek.  Southern and northern analysis. , 1993, Journal of chromatography.

[42]  Hans R. Schöler,et al.  New type of POU domain in germ line-specific protein Oct-4 , 1990, Nature.

[43]  M. Wegner,et al.  POU-domain proteins: structure and function of developmental regulators. , 1993, Current opinion in cell biology.

[44]  H. Schöler,et al.  A family of octamer‐specific proteins present during mouse embryogenesis: evidence for germline‐specific expression of an Oct factor. , 1989, The EMBO journal.

[45]  M. Glimcher,et al.  Gene Expression and Phosphorylation of Mouse Osteopontin a , 1995, Annals of the New York Academy of Sciences.

[46]  Y. Saijoh,et al.  Identification of putative downstream genes of Oct‐3, a pluripotent cell‐specific transcription factor , 1996, Genes to cells : devoted to molecular & cellular mechanisms.

[47]  P N Goodfellow,et al.  SRY, like HMG1, recognizes sharp angles in DNA. , 1992, The EMBO journal.

[48]  H. Schöler,et al.  Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation , 1998, Mechanisms of Development.

[49]  C. Pabo,et al.  Oct-1 POU domain-DNA interactions: cooperative binding of isolated subdomains and effects of covalent linkage. , 1996, Genes & development.

[50]  H. Schöler,et al.  A nexus between Oct-4 and E1 A: Implications for gene regulation in embryonic stem cells , 1991, Cell.

[51]  H. Schöler,et al.  In line with our ancestors: Oct‐4 and the mammalian germ , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[52]  A. Rizzino,et al.  The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells. , 1994, Biochemical and biophysical research communications.

[53]  K. Okamoto,et al.  A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells , 1990, Cell.

[54]  K. Artzt,et al.  Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. , 1996, The Journal of biological chemistry.

[55]  M. McPherson,et al.  PCR 2 : a practical approach , 2016 .

[56]  G. Martin,et al.  Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. , 1992, Development.

[57]  R. Roberts,et al.  Silencing of the Gene for the β Subunit of Human Chorionic Gonadotropin by the Embryonic Transcription Factor Oct-3/4* , 1996, The Journal of Biological Chemistry.

[58]  Rudolf Grosschedl,et al.  The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures , 1992, Cell.

[59]  P. Waterhouse,et al.  Regulated temporal and spatial expression of the calcium‐binding proteins calcyclin and opn (osteopontin) in mouse tissues during pregnancy , 1992, Molecular reproduction and development.

[60]  M. Ashburner.  A Laboratory manual , 1989 .

[61]  B. Hogan,et al.  Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization , 1988, The Journal of cell biology.

[62]  M. Rosenfeld,et al.  Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. , 1997, Genes & development.

[63]  C Sander,et al.  The use of position‐specific rotamers in model building by homology , 1995, Proteins.

[64]  A. Rizzino,et al.  Transcriptional regulation of the murine k‐fgf gene , 1994, Molecular reproduction and development.

[65]  H. Schöler,et al.  Structure, expression and chromosomal location of the Oct-4 gene , 1991, Mechanisms of Development.

[66]  S. C. Pruitt,et al.  Primitive streak mesoderm-like cell lines expressing Pax-3 and Hox gene autoinducing activities. , 1994, Development.

[67]  R. Beddington,et al.  Whole-mount in situ hybridization in the mouse embryo: gene expression in three dimensions. , 1993, Trends in genetics : TIG.